In this study, we found that Her-2 positive patients tended to have lower differentiation and higher tumor grade, which may be related to the high expression of CD4+ T cells as well as the relatively low expression of CD8+ T cells in the tumor stroma of the Her-2 positive group [16]. This evidence concerns the gene ERBB2 and neoplasm.